STEADY-STATE PHARMACOKINETICS OF 2 SUSTAINED-RELEASE THEOPHYLLINE PRODUCTS DURING ONCE-DAILY AND TWICE-DAILY DOSING

被引：0

作者：

ARMSTRONG, EP ^{[1
]}

NAKO, N ^{[1
]}

PLEZIA, PM ^{[1
]}

KRAMER, TH ^{[1
]}

JONES, WN ^{[1
]}

机构：

[1] UNIV ARIZONA,COLL PHARM,TUCSON,AZ 85721

来源：

CLINICAL PHARMACY | 1987年 / 6卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：800 / 804

页数：5

共 50 条

[41] COMPARISON OF SUSTAINED-RELEASE THEOPHYLLINE SCHEDULED CONVENTIONALLY (TWICE-DAILY, EQUAL INTERVAL IN EQUAL AMOUNT) VERSUS ONCE-DAILY MORNINGS OR EVENINGS ON CIRCADIAN PATTERN OF BRONCHIAL PATENCY IN ASTHMATICS [J].

FRANKOFF, HM ;

SMOLENSKY, MH ;

DALONZO, GE ;

GIANOTTI, L ;

HSI, B ;

MCGOVERN, JP .

CHRONOBIOLOGY INTERNATIONAL, 1987, 4 (03) :421-433

[42] Comparative evaluation of once-daily and twice-daily dosing of topical bromfenac 0.09%: aqueous pharmacokinetics and clinical efficacy study [J].

Titiyal, Jeewan S. ;

Thangavel, Rajeswari ;

Kaur, Manpreet ;

Venkatesh, Pradeep ;

Velpandian, T. ;

Sinha, Rajesh .

JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2021, 47 (09) :1115-1121

[43] Steady-state pharmacokinetics of a multiparticulate matrix sustained-release theophylline preparation [J].

Peh, KK ;

Yuen, KH .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (11) :1133-1138

[44] Twice-daily to once-daily lopinavir/ritonavir pharmacokinetics-pharmacodynamics in pediatric patients [J].

Foissac, F. ;

Blanche, S. ;

Hirt, D. ;

Treluyer, J. M. ;

Urien, S. .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 :60-60

[45] GALENICAL DEVELOPMENT OF A NEW SUSTAINED-RELEASE THEOPHYLLINE PELLET FORMULATION FOR ONCE-DAILY ADMINISTRATION [J].

BENEDIKT, G ;

STEINIJANS, VW ;

DIETRICH, R .

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-2 (8A) :1203-1209

[46] DAY NIGHT PATTERNS IN BRONCHIAL PATENCY AND DYSPNEA - BASIS FOR ONCE-DAILY AND UNEQUALLY DIVIDED TWICE-DAILY THEOPHYLLINE DOSING SCHEDULES [J].

SMOLENSKY, MH ;

DALONZO, GE ;

KUNKEL, G ;

BARNES, PJ .

CHRONOBIOLOGY INTERNATIONAL, 1987, 4 (03) :303-317

[47] A Randomized Study to Demonstrate Noninferiority of Once-Daily OROS® Hydromorphone with Twice-Daily Sustained-Release Oxycodone for Moderate to Severe Chronic Noncancer Pain [J].

Binsfeld, Heinrich ;

Szczepanski, Leszek ;

Waechter, Sandra ;

Richarz, Ute ;

Sabatowski, Rainer .

PAIN PRACTICE, 2010, 10 (05) :404-415

[48] Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma [J].

Kuna, P. ;

Creemers, J. P. H. M. ;

Vondra, V. ;

Black, P. N. ;

Lindqvist, A. ;

Nihlen, U. ;

Vogelmeier, C. .

RESPIRATORY MEDICINE, 2006, 100 (12) :2151-2159

[49] CHRONOPHARMACOKINETICS IN STEADY-STATE OF A SUSTAINED-RELEASE THEOPHYLLINE [J].

SEGRESTAA, JM ;

DAHAN, R ;

HOULBERT, D ;

CAULIN, C ;

RONNEL, A ;

ABELLA, ML .

THERAPIE, 1984, 39 (06) :633-637

[50] CHRONIC OBSTRUCTIVE PULMONARY-DISEASE TREATMENT WITH UNEQUAL TWICE-DAILY SUSTAINED-RELEASE THEOPHYLLINE [J].

BRUGUEROLLE, B ;

PHILIPJOET, F ;

PARREL, M ;

VESTRI, R ;

ARNAUD, A .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (05) :402-402

← 1 2 3 4 5 →